Close filter

Ben Maddox

联系信息

+44 207 943 5817

请联系我

Ben Maddox is active globally in Egon Zehnder’s Health Practice. He is an experienced strategic advisor with specialized expertise in pharma, biotech, and life sciences, with a passion for the benefits that science and innovation can bring to patients. Ben leads Executive and Board searches, as well as providing assessment and development support for senior leaders. He has a particular interest in C-suite and R&D leadership roles.

People are at the core of the health sector, both as patients and as leaders. I am energized by finding and developing the best leaders and enabling them to bring exciting scientific innovations to market.

Prior to joining Egon Zehnder, Ben was a Principal at IQVIA. At IQVIA he led the Cambridge, UK office and advised international pharma, biotech, and medical device clients on a wide range of business issues, including pricing and market access, clinical evidence generation, and brand strategy.

He holds a PhD in biochemistry and Masters in Natural Sciences from the University of Cambridge. Ben still lives in Cambridge with his wife and young daughters. Outside of work he enjoys spending time tinkering with technology.

我的专长领域

联系我们
Send Ben a Message
浏览全部
智识与洞见

全球相关顾问

Kiné Seck Mercier

Kiné Seck Mercier

Paris, Sub-Saharan Africa

Kiné Seck Mercier leads Egon Zehnder’s Enterprise Technology Practice in EMEA, with particular expertise in scale up Tech businesses, Software /… 阅读更多

Alex Payne

Alex Payne

Boston

Based in Boston, Alex Payne is active in Egon Zehnder’s Energy and Industrial practices, and leads the North American Power, Utilities and Renewables… 阅读更多

Ekaterina Bozoukova

Ekaterina Bozoukova

Frankfurt

Based in Frankfurt, Ekaterina Bozoukova is an active member of Egon Zehnder’s Investment Banking, Private Equity, Fintech, Blockchain… 阅读更多

Changing language
Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top